Abstract:Objective To evaluate the efficacy of intra-arterial hrombolytic therapy in patients with acute ischemic stroke having their time window over 3 h and analyze its influencing factors.Methods Sixteen patients with acute ischemic stroke having their time window over 3 h, admitted to Department of Neuroradiology of Central Hospital of Nancy University from January 2008 to January 2009, were treated by intra-arterial thrombolysis using chemical (rt-PA) and mechanical technique. These patients had carotid stroke for less than 3 h, vertebrobasilar stroke for less than 24 h or coma for less than 6 h. According to the images of DSA, the recanalization after thrombolysis was evaluated by thrombolysis in cerebral infarction (TICI) grades. CT scans 24 h after thrombolysis were operated to detect the hemorrhage complications. NIHSS at baseline and 24 h after thrombolysis and modified Rankin Scale (mRS) were recorded to evaluate the clinical efficacy. Results After intra-arterial thrombolysis, 7 (43.75%) in 16 patients got totally recanalization (TICI grade 3), another 7 partial recanalization (TICI grade 2), and the left 2 patients failed in recanalization (TICI grade 1); the total recanalization rate was 87.5%. A significant reduction of NIHSS scores after the thrombolysis was noted as compared with that before the thrombolysis. The atients with occlusion of anterior ciculation having time window over 5 h enjoyed no reduction of NIHSS scores after thrombolysis; mRS scores in patients having time window over 5 h were ignificantly higher as compared with those in patients having time window less than 5 h.The patients having ICA occlusion (n=5) had no reduction of NIHSS scores after thrombolysis, and enjoyed poorer prognosis as compared with whose occlusion lay in the middle cerebral artery (MCA,n=9) and basilar artery (BA, n=2). By CT scan 24 h after thrombolysis, 4 patients were detected with symptomatic intra cerebral hemorrhage (ICH, 25%) and all of them with occlusion in the internal carotid artery system: 1 patient with occlusion in MCA died of cerebral hernia causing by the large hematoma;the other 3 were all occlusion in ICA. Although reocclusion after thrombolysis occurred, 1 patient was benefitted from the affluent collateral perfusion and got a good prognosis. Conclusion For patientswith BA and MCA occlusion having time window over 3 h, intra-arterial thrombolytic therapy is effective and selective resulting from their high recanalization rate, improvement of neurological function and clinical end. The therapy should be individually chosen; mutiple factors as time window of stroke,location of stroke, ompensatory circulation and complications should be considered in evaluating the efficacy; and the hemorrhage complications should be avoided.

Meta-analysis of clinical outcomes of intravenous recombinant tissue plasminogen activator for acute ischemic stroke: within 3 hours versus 3-4.5 hours

Efficacy of Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Meta-Analysis.

Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours

Non-atrial Fibrillation Was Associated with Early Neurological Improvement after Intravenous Thrombolysis with Rt-Pa in Patients with Acute Ischemic Stroke

Comparison of Therapeutic Effect of Recombinant Tissue Plasminogen Activator by Treatment Time after Onset of Acute Ischemic Stroke

Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke-a Single Center Retrospective Study

Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator.

Efficacy and Safety of Rt-Pa Intravenous Thrombolysis for Treating Acute Ischemic Stroke Beyond the Therapeutic Window: a Meta-analysis

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

Abstract W P10: Endovascular Treatment for Anterior Circulation Stroke Leads to Similar Outcomes in Very Early (within 3 Hours) Versus Selected Late (beyond 8 Hours) Presenting Patients

Therapeutic Effect of Recombinant Tissue Plasminogen Activator on Acute Cerebral Infarction at Different Times.

Efficacy and Safety of Recombinant Tissue-type Plasminogen Activator for Acute Ischemic Stroke:A Meta-analysis

Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion # 3 h and 3-6 h

Low-dose tissue plasminogen activator is as effective as standard tissue plasminogen activator administration for the treatment of acute ischemic stroke.

Safety and Outcome of Thrombolysis in Acute Stroke with Prolonged Onset-to-Treatment Times and Low National Institute of Health Stroke Scale Scores. Report on Experience in China, First 1000 Patients of 3300 Treated (P2.284)

The Clinical Study of Thrombolysis with rt-PA in Acute Ischemic Stroke

Abstract TP75: Safety and Outcome of Thrombolysis in Acute Stroke with Prolonged Onset-to-Treatment Times and Low National Institute of Health Stroke Scale Scores. Report on Experience in China, First 1000 Patients of 3300 Treated

Case Analysis of Intravenous Thrombolysis in the Expanded Time Window under the Guidance of Multimode CT

In-hospital Outcomes of Intravenous Recombinant Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke in Patients Aged >80 Years: Findings from the Chinese Stroke Center Alliance

Intra-arterial thrombolytic therapy in patients with acute ischemic stroke having their time window over 3 hours

Effects of application of multimode CT evaluation in the intravenous thrombolytic therapy with recombinant tissue plasminogen activator after stroke